Home / Companies / Supernus Pharmaceuticals, Inc. / 16 Jun 2025
Supernus Pharmaceuticals, Inc.: meeting of 16 Jun 2025
Votes reported on Form N-PX, item by item
435 Form N-PX filers reported votes at the Supernus Pharmaceuticals, Inc. meeting of 16 Jun 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 92.3% of reported votes for; 26 filers withheld from or voted against at least one nominee.
618 vote records from 156 filers. 2 of the 155 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
637 vote records from 430 filers. 24 of the 420 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
309 vote records from 156 filers. 6 of the 155 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCESecurity holder
To consider and vote upon a stockholder proposal, if included in our Proxy Statement for the Annual...
102 vote records from 57 filers. 26 of the 36 filers that marked the item either way voted against management. 21 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 4. Proposal |
|---|---|---|---|---|
| Vanguard | For | For | For | Abstain or withhold |
| BlackRock and iShares | For | For | For | Abstain or withhold * |
| Fidelity | For | For | For | No report |
| Dimensional | No report | For | No report | No report |
| State Street and SPDR | For | For | For | No report |
| American Century | For | For | For | No report |
| Franklin Templeton | For | For | For | No report |
| Invesco | Split or no vote | For | For | No report |
| Equitable | For | For | For | No report |
| Charles Schwab | For | For | For | Abstain or withhold |
| Nuveen and TIAA | Split or no vote | For | For | No report |
| ProShares and ProFunds | For | For | For | No report |
| John Hancock and Manulife | For | For | For | Abstain or withhold * |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For | No report |
| J.P. Morgan | For | For | For | Abstain or withhold * |
| Goldman Sachs | For | For | For | Abstain or withhold * |
| WisdomTree | For | For | For | No report |
| PGIM and Prudential | For | For | For | Abstain or withhold |
| Jackson National funds | For | For | For | Abstain or withhold * |
| Northern Trust and FlexShares | For | For | For | No report |
| SEI | For | For | For | Abstain or withhold |
| T. Rowe Price | Split or no vote | For | For | No report |
| Thrivent | For | For | For | No report |
| Lincoln Financial | For | For | For | No report |
| Voya | For | For | For | No report |
| First Trust | For | For | For | No report |
| Russell Investments | For | For | For | Against |
| Nationwide | For | For | For | Abstain or withhold |
| Victory Capital | For | For | For | No report |
| Brighthouse Funds | For | For | For | No report |
| Guggenheim and Rydex | For | For | For | No report |
| Columbia Threadneedle | For | For | For | No report |
| BNY Mellon | For | For | For | No report |
| Principal | For | For | For | Abstain or withhold |
| Pacific Life funds | For | For | For | No report |
| Global X | For | For | For | No report |
| Transamerica | For | For | For | Abstain or withhold |
| Federated Hermes | For | For | For | Abstain or withhold |
| AllianceBernstein | No report | For | No report | No report |
| DWS | For | For | For | No report |
| Allspring | No report | For | No report | No report |
| MassMutual | No report | For | No report | No report |
| Macquarie and Delaware Funds | For | For | For | No report |
| Neuberger Berman | No report | For | No report | No report |
| American Beacon | For | For | For | No report |
| Natixis and Loomis Sayles | For | For | For | Abstain or withhold * |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Supernus Pharmaceuticals, Inc. meeting?
435 Form N-PX filers reported votes at the meeting of 16 Jun 2025. On say-on-pay, 24 of 420 voted against management (5.7%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Supernus Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Supernus Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Supernus Pharmaceuticals, Inc. with a meeting date within three days of 16 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.